Previous close | 23.80 |
Open | 25.80 |
Bid | 19.70 |
Ask | 26.90 |
Strike | 360.00 |
Expiry date | 2026-01-16 |
Day's range | 23.80 - 25.80 |
Contract range | N/A |
Volume | |
Open interest | 34 |
Although the revenue and EPS for Vertex (VRTX) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Vertex Pharmaceuticals ( NASDAQ:VRTX ) First Quarter 2024 Results Key Financial Results Revenue: US$2.69b (up 13% from...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Q1 2024 Earnings Call Transcript May 6, 2024 Vertex Pharmaceuticals Incorporated beats earnings expectations. Reported EPS is $4.76, expectations were $4.07. Vertex Pharmaceuticals Incorporated isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome […]